Marken, a wholly owned subsidiary of UPS Inc. that manages clinical drug supply chain services, said Monday it has expanded its global network primarily to support increased demand for cell and gene therapy clinical trials.
Expansion plans include new locations, additional cold chain services and packaging solutions, said Marken, which is based in Research Triangle, North Carolina.
As part of the geographic expansion, Marken will develop facilities in South Korea and sub-Saharan Africa, the...